Cellgenix USA

UEI
CCYHJN1KNAM6
CAGE
6ZA41
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
International Organization
SAM.gov registration date
Website
sartorius.com
Founded
1870
Employees
10K-50K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$16,869
FY2025 $0
FY2024 -$520

Contract awards

Award Agency Obligated Awarded
GMP FLT-3L, 50 UG, GMP SCF, 50 UG, and GMP TPO, 50 UG. 75N90022P00025 NIH Clinical Center $20,607
GMP FLT-3L, 50 UG 75N90021P00738 NIH Clinical Center $29,092
Various cellgenix cytokines reagents. 75N90021P00581 NIH Clinical Center $51,410
Cellgenix GMP RH GM-CSF CAT no:001012-1000 75N93021P00868 National Institute of Allergy and Infectious Diseases (NIH) $0
GMP FLT-3L, 50 UG, -GMP SCF, 50 UG, and GMP TPO, 50 UG. 75N90021P00365 NIH Clinical Center $17,113

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Proteios Technology, Inc. UEI G6QLLQD9UMT1 Issaquah, WA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Editco Bio Inc. UEI MN9PSNE16SJ8 Redwood City, CA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
DNA Twopointo Inc. UEI G9S3SC8T5DM1 Newark, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Stembiosys Inc. UEI QNQQJ5K2KXG9 San Antonio, TX 238990 All Other Specialty Trade Contractors
Ossium Health, Inc. UEI FFNHJ2RDRHW3 Indianapolis, IN 325414 Biological Product (except Diagnostic) Manufacturing

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Cellgenix USA Cellgenix GMBH Division is a leading global supplier of high quality raw and ancillary materials for the cell and gene therapy market. The company provides various cytokines, growth factors, and other pharmaceuticals to support cell and gene therapy research and development.

Through past prime federal contract awards, Cellgenix USA has provided specialized cell therapy-related pharmaceuticals such as GMP cytokines, growth factors, and interleukins to the National Institutes of Health Clinical Center and National Institute of Allergy and Infectious Diseases. Specific goods provided include FLT-3L, SCF, TPO, GM-CSF, interleukin-4 and other cell therapy reagents, with contract award values ranging from $11,942 to $51,410. The contract awards have been prime contracts with no set aside designations, structured as purchase orders and completed on schedule based on the listed completion dates. Cellgenix USA has established itself as a consistent provider of high quality raw materials to support federal cell and gene therapy research initiatives.

Quick answers

Is Cellgenix USA registered in SAM.gov?

Cellgenix USA's SAM.gov registration expired on December 8, 2021.

What is Cellgenix USA's CAGE code?

Cellgenix USA's CAGE code is 6ZA41, and its Unique Entity ID (UEI) is CCYHJN1KNAM6.

What is Cellgenix USA's most recent federal award?

Cellgenix USA's most recent federal contract award is GMP FLT-3L, 50 UG, GMP SCF, 50 UG, and GMP TPO, 50 UG (75N90022P00025), from NIH Clinical Center, on November 2, 2021.

On GovTribe

See Cellgenix USA's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe